This article was written by Rebekah Apple.
Right now, more than 107,000 Americans wait for a life-saving organ transplant. The list grows with another name every 11 minutes, and every day, 18 people on that list die.
One organ donor can save eight people’s lives and a tissue donor can help up to 50 others. The fact remains, however, that there simply aren’t enough organs to save everyone on the waiting list.
Signing up to become a donor is easy — most Americans can designate themselves as donors when they get their drivers license and, in many states, that designation transfers their information to a state database. In the event of their death, organ donation professionals access that database, which begins the process of saving lives.
Making the decision to become a donor is different; it requires a clear understanding of the way donation works — which can prove difficult, given various persistent myths about donation.
Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following a blood stem cell transplant had their cancer kept in check longer than patients who received a placebo. The clinical trial, for patients ages 18 to 70, was sponsored by the National Cancer Institute (NCI), and conducted by a network of researchers led by the Cancer and Leukemia Group B (CALGB) in collaboration with the Eastern Cooperative Oncology Group (ECOG) and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). The BMT CTN is co-sponsored by NCI and the National Heart, Lung, and Blood Institute, both parts of the National Institutes of Health.
Read the full news release ...
Seasons Greetings! Welcome to the Holiday Edition of Grand Rounds, featuring some of the best articles of the biomedical and healthcare blogosphere.
There’s a revolution occurring on the Web: those “authoritative” articles written on traditional, static websites are being replaced with blogs, wikis and online social networks. In the sphere of health, medicine and information technology, this “real-time Web” consists of many who are professionals in the field; their posts are listed below.
In the digital age, these are the characteristics of new media: recent, relevant, reachable and reliable.
At this time last year, I announced the Highlight HEALTH Network, a single source that aggregates content from all the Highlight HEALTH websites. This year, I have a similar gift for biomedical and healthcare blogosphere readers:
Health and Medicine blog carnival email and RSS subscriptions!